increas
yield
product
cell
culturebas
vaccin
manufactur
use
highcelldens
hcd
cultiv
face
number
challeng
exampl
medium
consumpt
low
obtain
high
concentr
viabl
host
cell
econom
way
must
balanc
requir
accumul
toxic
metabolit
limit
nutrient
avoid
hcd
cultiv
also
optim
avoid
unwant
induct
apoptosi
autophagi
earli
phase
viru
infect
realiz
full
potenti
hcd
cultiv
ration
analysi
cultiv
condit
appropri
host
cell
line
togeth
optim
infect
condit
chosen
viral
vaccin
strain
need
perform
particular
manufactur
process
illustr
strategi
product
modifi
vaccinia
ankara
mva
viru
isol
avian
suspens
cell
line
hcd
first
step
demonstr
adjust
perfus
rate
strictli
base
measur
cell
concentr
glucos
consumpt
rate
cell
enabl
optim
growth
l
bioreactor
equip
system
concentr
cellsml
infect
obtain
viabil
exceed
maximum
specif
cell
growth
rate
h
doubl
time
h
howev
cellspecif
viru
yield
also
volumetr
product
reduc
compar
infect
conventionalcelldens
ccd
facilit
optim
viru
propag
phase
hcd
larger
set
feed
strategi
analyz
smallscal
cultiv
use
shake
flask
densiti
cellsml
obtain
end
cell
growth
phase
appli
discontinu
perfus
mode
semiperfus
cellspecif
perfus
rate
bioreactor
nl
cell
cell
concentr
medium
exchang
time
infect
requir
obtain
expect
viru
yield
first
h
infect
appli
addit
fedbatch
feed
strategi
whole
viru
replic
phase
result
faster
viru
titer
increas
first
h
infect
contrast
semicontinu
viru
harvest
scheme
improv
viru
accumul
recoveri
rather
later
stage
infect
overal
combin
fedbatch
medium
exchang
strategi
result
similar
cellspecif
viru
yield
obtain
ccd
process
higher
titer
four
time
higher
volumetr
product
increas
yield
product
cell
culturebas
vaccin
manufactur
use
highcelldens
hcd
cultiv
face
number
challeng
exampl
medium
consumpt
low
obtain
high
concentr
viabl
host
cell
econom
way
must
balanc
requir
accumul
toxic
metabolit
limit
nutrient
avoid
hcd
cultiv
also
optim
avoid
unwant
induct
apoptosi
autophagi
earli
phase
viru
infect
realiz
full
potenti
hcd
cultiv
ration
analysi
cultiv
condit
appropri
host
cell
line
togeth
optim
infect
condit
chosen
viral
vaccin
strain
need
perform
particular
manufactur
process
illustr
strategi
product
modifi
vaccinia
ankara
mva
viru
isol
avian
suspens
cell
line
hcd
first
step
demonstr
adjust
perfus
rate
strictli
base
measur
cell
concentr
glucos
consumpt
rate
cell
enabl
optim
growth
l
bioreactor
equip
system
concentr
cellsml
infect
obtain
viabil
exceed
maximum
specif
cell
growth
rate
h
doubl
time
h
howev
cellspecif
viru
yield
also
volumetr
product
reduc
compar
infect
conventionalcelldens
ccd
facilit
optim
viru
propag
phase
hcd
larger
set
feed
strategi
analyz
smallscal
cultiv
use
shake
flask
densiti
cellsml
obtain
end
cell
growth
phase
appli
discontinu
perfus
mode
semiperfus
cellspecif
perfus
rate
bioreactor
nl
cell
cell
concentr
medium
exchang
time
infect
requir
obtain
expect
viru
yield
first
h
infect
appli
addit
fedbatch
feed
strategi
whole
viru
replic
phase
result
faster
viru
titer
increas
first
h
infect
contrast
semicontinu
viru
harvest
scheme
improv
viru
accumul
recoveri
rather
later
stage
infect
overal
combin
fedbatch
medium
exchang
strategi
result
similar
cellspecif
viru
yield
obtain
ccd
process
higher
titer
four
time
higher
volumetr
product
elsevi
ltd
right
reserv
modern
recombin
vector
vaccin
combin
advantag
attenu
even
hostrestrict
infect
highli
immunogen
express
antigen
choic
especi
promis
vector
highli
attenu
poxvirus
includ
modifi
vaccinia
viru
ankara
mva
mva
attenu
repeat
passag
chicken
fibroblast
cultur
properti
potenti
human
vector
vaccin
well
character
variou
mva
recombin
express
differ
viral
heterolog
antigen
gener
extens
test
preclin
clinic
trial
candid
vaccin
diseas
aid
influenza
sever
acut
respiratori
syndrom
sar
human
respiratori
syncyti
viru
rsv
infect
use
mva
vectorbas
vaccin
howev
predict
requir
highli
concentr
dose
infecti
unit
iu
per
ml
prefer
produc
media
free
animalderiv
compon
mva
similar
virus
influenza
viru
yellow
fever
viru
produc
materi
obtain
embryon
chicken
egg
primari
chicken
embryo
fibroblast
cef
howev
use
primari
animalderiv
materi
continu
fed
vaccin
product
process
optim
scenario
overcom
problem
two
fulli
permiss
avian
suspens
cell
line
follow
cr
follow
crpix
develop
adapt
prolifer
chemic
defin
medium
enabl
establish
robust
highyield
product
process
mva
spread
prefer
via
celltocel
contact
cultur
format
develop
cell
agglomer
infect
noninfect
cell
induc
product
vaccin
prepar
mva
strain
recent
obtain
system
propag
also
nonagglomer
crpix
suspens
cell
new
isol
repres
differ
genotyp
mva
titer
order
iuml
obtain
conventionalcelldens
ccd
cellsml
higher
fraction
releas
supernat
harvest
infecti
unit
requir
wholecel
lysat
anymor
facilit
subsequ
downstream
process
increas
viru
titer
highcelldens
hcd
process
establish
viru
propag
hcd
often
result
either
decreas
cellspecif
yield
socal
celldens
effect
low
volumetr
product
report
posit
effect
viru
titer
cellspecif
yield
certain
medium
feedingexchang
strategi
prior
viru
propag
appli
describ
strategi
involv
medium
recircul
medium
perfus
period
viru
harvest
howev
approach
adher
cell
line
use
limit
option
scaleup
process
intensif
author
describ
use
suspens
cell
cellsml
without
address
detail
optim
analysi
regard
effect
variou
medium
feed
strategi
infect
yield
product
suspens
crpix
cell
hcd
cellsml
present
cultiv
perform
perfus
bioreactor
shake
flask
smallscal
model
demonstr
appli
optim
feed
strategi
hcd
similar
cellspecif
viru
yield
obtain
maximum
viru
titer
well
volumetr
product
increas
significantli
compar
ccd
cultiv
suspens
crpix
cell
cultiv
chemic
defin
medium
biochrom
gmbh
glucos
concentr
mm
supplement
glutamin
alanin
mm
final
concentr
sigma
recombin
insulinlik
growth
factor
ngml
final
concentr
sigma
cell
passag
twice
week
seed
concentr
cellsml
crpix
cell
cultiv
labscal
bioreactor
biostat
b
plu
sartoriu
ag
work
volum
l
bioreactor
inocul
cellsml
precultur
expand
ml
shake
flask
oper
ph
stir
speed
rpm
dissolv
oxygen
concentr
control
puls
aerat
pure
oxygen
lm
pore
size
microsparg
maximum
vvm
repres
volumetr
oxygen
transfer
coeffici
k
l
h
rpm
cell
initi
cultiv
batch
glucos
concentr
mm
h
inocul
reach
point
perfus
start
use
perfus
system
control
control
refin
technolog
polysulfon
kda
hollow
fiber
cartridg
ge
healthcar
cell
suspens
pump
hollow
fiber
recircul
rate
lmin
fed
defin
perfus
rate
achiev
minimum
concentr
cellsml
feed
base
constant
cellspecif
perfus
rate
cspr
take
account
steadi
state
mass
balanc
substrat
describ
kompala
ozturk
glucos
major
energi
sourc
crpix
cell
dilut
rate
h
viabl
cell
concentr
x
cell
ml
cellspecif
glucos
consumpt
rate
q
gx
mmol
cell
h
base
previou
data
shown
glucos
concentr
medium
c
gm
mmolml
glucos
concentr
bioreactor
c
gr
mmolml
ratio
perfus
rate
q
mlh
reactor
work
volum
v
w
ml
perfus
rate
q
function
time
express
q
adjust
manual
accord
initi
cell
concentr
x
cover
increas
nutrient
demand
ie
glucos
next
sampl
time
point
simplic
reason
either
h
therefor
cascad
control
biostat
b
plu
modul
use
calcul
constant
cellspecif
growth
rate
l
h
consid
three
hour
infect
perfus
rate
set
time
calcul
valu
achiev
total
medium
exchang
reactor
volum
reduc
risk
nutrient
limit
dilut
unwant
byproduct
could
neg
affect
viru
propag
infect
perfus
rate
adjust
calcul
valu
appli
l
cell
growth
phase
hour
post
infect
hpi
specif
cell
death
rate
h
taken
account
compens
increas
cell
loss
due
progress
infect
base
previou
data
shown
smallscal
cultiv
carri
shake
flask
baffl
ml
ml
v
w
ml
ml
v
w
vwr
intern
llc
co
rpm
agit
speed
multitron
incub
shaker
infor
ag
cm
orbit
experi
ccd
shake
flask
inocul
cellsml
cultiv
h
reach
cellsml
infect
experi
hcd
inocul
procedur
perform
cell
cultiv
batch
h
start
semiperfus
semiperfus
carri
exchang
period
enough
medium
cover
glucos
demand
two
sampl
time
point
assum
medium
exchang
volum
v
e
equal
amount
medium
exchang
continu
perfus
process
time
period
v
e
deriv
solv
eq
v
e
dt
x
e
lt
v
w
cspr
obtain
depend
viabl
cell
concentr
x
initi
sampl
time
point
v
e
typic
less
v
w
calcul
consid
cspr
nl
cell
base
perfus
cultur
perform
bioreactor
dt
h
calcul
volum
remov
cell
cultur
centrifug
min
supernat
discard
cell
pellet
resuspend
volum
fresh
medium
return
shake
flask
fluctuat
concentr
medium
compon
avoid
regularli
adjust
frequenc
medium
exchang
maximum
v
w
order
assur
homogen
cell
popul
time
infect
toi
cell
expand
parallel
ml
shake
flask
ml
v
w
addit
time
point
medium
exchang
cell
shake
flask
pool
sampl
exchang
volum
calcul
base
pool
cell
concentr
minimum
target
concentr
cellsml
achiev
cell
distribut
ml
shake
flask
ml
v
w
infect
accordingli
toi
infect
compris
total
partial
medium
exchang
correspond
volum
cell
broth
centrifug
min
cell
pellet
resuspend
respect
volum
fresh
medium
contain
viru
requir
ph
monitor
onlin
use
sfr
system
presen
seed
viru
bank
isol
virionsml
propag
crpix
cell
prepar
describ
infect
seed
viru
aliquot
treat
min
sonic
water
bath
break
viru
aggreg
cultiv
infect
moi
multipl
infect
virionscel
infect
ccd
cellsml
perform
describ
lohr
dilut
cell
cultur
fresh
medium
contain
defin
amount
viru
henc
final
concentr
cellsml
obtain
infect
infect
hcd
seed
viru
dilut
fresh
medium
ad
total
partial
medium
exchang
toi
perform
infect
bioreactor
medium
exchang
perform
viru
dilut
fresh
medium
volum
equal
v
w
ad
cell
cultur
quantif
concentr
infecti
viru
particl
lysat
infect
cell
treat
three
freez
thaw
cycl
treat
min
sonic
water
bath
khz
prior
centrifug
min
rt
discard
cellular
debri
quantif
viru
releas
host
cell
supernat
sampl
centrifug
min
rt
supernat
retriev
treat
also
three
freez
thaw
cycl
storag
viru
sampl
store
aliquot
ml
viru
quantif
perform
tcid
describ
previous
cellspecif
viru
yield
vcell
virionscel
calcul
base
total
number
infecti
viru
particl
vir
total
number
cell
produc
cell
latter
differ
number
cell
toi
sinc
cell
growth
typic
observ
hpi
similarli
volumetr
product
p
v
virion
l
calcul
consid
vir
total
spent
medium
cell
growth
viru
replic
phase
v
l
total
process
time
use
eq
order
analyz
product
differ
time
point
viru
infect
phase
appar
cellspecif
viru
yield
vcell
app
virionscel
calcul
consid
number
viru
particl
produc
time
point
vir
acc
number
cell
infect
hpi
cell
accord
eq
sampl
bioreactor
cultur
taken
syring
ml
luerlockseptum
h
interv
store
analysi
determin
glucos
lactat
concentr
valid
assay
use
bioprofil
plu
nova
biomed
use
describ
previous
cell
concentr
determin
cell
counter
vicellxr
beckman
coulter
valid
rel
standard
deviat
percentag
infect
cell
differ
time
point
post
infect
determin
flow
cytometri
total
amount
infect
cell
fix
use
paraformaldehyd
min
fix
cell
wash
phosphat
buffer
salin
pb
permeabil
tween
pb
min
cell
immunostain
dilut
fitcconjug
polyclon
antivaccinia
antibodi
quartett
gmbh
stain
buffer
contain
pb
plu
foetal
calf
serum
fc
h
dark
rt
use
imagestream
x
mark
ii
amni
emd
millipor
singl
cell
per
sampl
debri
cell
doublet
exclud
analyz
wavelength
nm
mv
intens
data
analysi
perform
use
idea
flowjo
softwar
refer
infect
use
crpix
cell
ccd
carri
ml
v
w
shake
flask
ccd
infect
shake
flask
maximum
titer
virionsml
obtain
hpi
fig
h
later
compar
jordan
et
al
bioreactor
tabl
cbwt
thu
result
obtain
consid
repres
ccd
infect
previou
experi
use
system
cultiv
cr
cell
show
suitabl
hollow
fiberbas
perfus
bioreactor
product
influenza
viru
hcd
cr
cell
specif
oxygen
uptak
rate
mmol
cell
h
determin
previous
assum
similar
rate
crpix
cell
k
l
h
would
requir
achiev
cellsml
accordingli
oper
condit
match
determin
previous
bioreactor
k
l
h
oxygen
limit
expect
concentr
target
cellsml
perfus
bioreactor
medium
feed
regim
describ
see
materi
method
led
constant
cell
specif
growth
rate
h
doubl
time
h
except
short
overfeed
h
due
failur
control
feed
pump
fig
b
correct
failur
medium
addit
stop
h
medium
remov
hollow
fiber
recov
origin
v
w
l
perfus
restart
use
initi
regim
cellsml
viabil
final
obtain
h
inocul
fig
expect
perfus
control
led
stabl
cspr
nl
cell
demonstr
robust
feed
strategi
chosen
also
medium
util
consider
reduc
reactor
volum
v
r
compar
almost
v
r
report
previous
cr
cell
cellsml
similar
specif
growth
rate
h
obtain
extens
medium
exchang
last
h
infect
result
increas
glucos
concentr
mm
despit
adjust
perfus
rate
averag
cspr
nl
cell
infect
glucos
concentr
show
consider
drop
mm
first
hpi
order
prevent
glucos
limit
earli
stage
viru
replic
cspr
increas
hpi
fig
afterward
perfus
rate
readjust
theoret
glucos
consumpt
rate
given
initi
titer
virionsml
correspond
actual
viru
concentr
expect
moi
loss
nm
size
virion
kda
atf
membran
neglig
addit
absenc
activ
viru
permeat
line
data
shown
along
whole
process
indic
viral
particl
inde
retain
within
reaction
volum
maximum
viru
titer
virionsml
hpi
fig
c
almost
increas
viru
titer
compar
refer
infect
ccd
shake
flask
virionsml
achiev
time
point
post
infect
fig
overal
cellspecif
yield
virionscel
obtain
tabl
lower
refer
infect
ccd
shake
flask
tabl
report
valu
tabl
cswt
interestingli
hcd
cultiv
concentr
viabl
cell
increas
significantli
infect
fig
addit
percentag
infect
cell
low
first
hpi
fig
suggest
delay
viru
uptak
onset
intracellular
viru
replic
given
total
amount
medium
employ
biomass
expans
viru
propag
volumetr
product
also
lower
compar
ccd
experi
tabl
taken
togeth
two
key
factor
seem
import
improv
hcd
cultiv
optim
infect
condit
achiev
fast
viru
replic
addit
seed
viru
b
minim
medium
util
entir
viru
propag
phase
without
compromis
final
viru
titer
order
address
two
target
sever
feed
strategi
assess
viru
replic
phase
smallscal
shake
flask
condit
batch
cultiv
crpix
cell
baffl
shake
flask
previous
optim
concentr
cellsml
viabil
routin
obtain
data
shown
howev
whether
condit
especi
shake
frequenc
rpm
could
fulfil
oxygen
transfer
requir
achiev
cell
concentr
cell
ml
clear
also
suitabl
manual
medium
exchang
centrifug
semiperfus
mimic
perfus
shake
flask
demonstr
henc
k
l
describ
cultiv
condit
rpm
shake
frequenc
estim
base
empir
correl
describ
shake
flask
geometr
configur
schiefelbein
et
al
describ
cultiv
condit
k
l
h
expect
ml
v
w
ml
ml
v
w
shake
flask
respect
valu
time
higher
report
k
l
h
perfus
bioreactor
describ
subsequ
scaledown
ml
v
w
shake
flask
analyz
consid
specif
cell
growth
rate
glucos
lactat
concentr
ph
key
paramet
appli
constant
cspr
nl
cell
cell
concentr
cellsml
fig
specif
growth
rate
h
achiev
constant
medium
renew
allow
maintain
ing
glucos
lactat
concentr
similar
level
hcd
bioreactor
cultiv
fig
addit
ph
valu
rang
fig
correspond
setpoint
bioreactor
cultiv
expect
maintain
high
level
fig
therefor
oxygen
suppli
consid
critic
hcd
cultiv
describ
follow
character
gener
growth
properti
crpix
cell
hcd
effect
medium
exchang
toi
viru
yield
analyz
without
medium
exchang
toi
maximum
viru
titer
virionsml
obtain
hpi
fig
despit
subsequ
addit
glucoseconcentr
medium
hpi
fedbatch
fb
avoid
energi
deplet
led
low
cellspecif
yield
virionscel
volumetr
product
virion
l
tabl
one
log
lower
compar
hcd
cultiv
bioreactor
tabl
compar
infect
ccd
differ
even
larger
tabl
howev
product
consider
improv
singl
medium
exchang
toi
follow
addit
concentr
medium
hpi
glucos
deplet
despit
shortterm
glucos
limit
neg
effect
later
viru
propag
observ
maximum
viru
titer
virionsml
obtain
hpi
lysat
supernat
fig
demonstr
produc
virus
harvest
supernat
hpi
need
celldisrupt
oper
eg
freezethaw
observ
previous
ccd
infect
cellspecif
yield
virionscel
volumetr
product
virion
l
tabl
result
achiev
rang
hcd
perfus
cultur
perform
bioreactor
tabl
suggest
medium
exchang
toi
rather
exclus
glucos
suppli
fb
concentr
medium
requir
boost
viru
propag
especi
hpi
fig
also
report
glutamin
play
minor
role
energi
suppli
crpix
cell
absenc
might
influenc
propag
mva
cell
line
therefor
posit
effect
medium
exchang
toi
viru
propag
might
also
due
dilut
inhibitori
metabolit
signal
molecul
rather
better
suppli
substrat
final
step
combin
medium
exchang
toi
variou
feed
strategi
use
medium
investig
cellular
materi
hcd
cultur
gener
two
ml
v
w
batch
cultur
two
ml
shake
flask
order
shorten
cell
growth
phase
cell
inocul
cellsml
semiperfus
perform
strict
control
time
frequenc
medium
exchang
cell
concentr
increas
without
notic
lag
phase
maximum
specif
growth
rate
h
h
similar
batch
cultiv
cultur
split
three
ml
shake
flask
cellsml
obtain
investig
infect
strategi
describ
reduc
risk
glucos
limit
observ
hpi
medium
exchang
toi
medium
exchang
toi
follow
three
altern
feed
strategi
analyz
fedbatch
fb
similar
strategi
volumeexpand
fedbatch
vefbatch
protocol
use
product
parapoxviru
ovi
bovin
kidney
cell
previous
report
pohlscheidt
et
al
carri
medium
volum
equal
work
volum
toi
ie
ml
ad
time
point
hpi
fig
hpi
work
volum
ml
reach
maximum
work
volum
ml
shake
flask
cell
suspens
transfer
ml
shake
flask
continu
experi
ii
daili
medium
exchang
dme
cultur
supernat
exchang
everi
h
achiev
centrifug
complet
volum
shake
flask
min
follow
harvest
supernat
addit
fresh
medium
v
w
toi
ml
iii
combin
fedbatch
daili
medium
exchang
f
medium
ad
fedbatch
mode
see
hpi
cultur
supernat
exchang
hpi
supernat
collect
product
harvest
v
w
toi
ml
even
medium
exchang
toi
hpi
could
complet
prevent
temporari
deplet
glucos
within
dme
strategi
fig
hpi
similarli
glucos
limit
observ
hpi
fd
fig
strategi
howev
shortterm
limit
compromis
viru
propag
viru
titer
higher
virionsml
within
first
hpi
fig
experi
perform
better
medium
exchang
fig
interestingli
increas
volum
fb
fig
fd
fig
first
hpi
result
notic
reduct
viru
titer
compar
dme
strategi
fig
posit
effect
volum
chang
viru
titer
despit
expect
reduct
due
product
dilut
also
document
previous
volumeexpand
fedbatch
strategi
hpi
dme
strategi
show
slight
decreas
viru
accumul
compar
strategi
possibl
due
remov
infecti
particl
harvest
supernat
glucos
limit
hpi
contrast
fb
fd
strategi
titer
virionsml
reach
hpi
nevertheless
daili
exchang
medium
dme
fd
strategi
extend
viru
product
phase
allow
achiev
viru
titer
virionsml
hpi
contrast
maximum
titer
virionsml
fb
time
point
fig
product
harvest
supernat
obtain
dme
fd
strategi
show
consist
similar
viru
titer
lysat
except
harvest
hpi
fd
even
titer
hpi
titer
rang
also
obtain
jordan
et
al
accordingli
propag
crpix
cell
requir
disrupt
step
host
cell
achiev
high
product
titer
hcd
cultiv
anoth
comparison
differ
feed
strategi
increas
vcell
app
cell
infect
hpi
taken
account
p
v
infect
time
shown
fig
b
respect
fbbase
strategi
superior
dme
strategi
regard
onset
viru
releas
maximum
vcell
app
furthermor
maximum
vcell
app
fd
strategi
exce
yield
approach
factor
two
three
regard
p
v
differ
feed
strategi
smaller
expect
differ
becom
less
evid
overal
cellspecif
yield
tabl
take
account
cell
produc
even
toi
howev
fbbase
strategi
fb
fd
show
two
time
higher
maximum
cellspecif
yield
compar
dme
tabl
indic
optim
balanc
mainten
healthi
cell
progress
viru
replic
observ
also
support
higher
percentag
infect
cell
obtain
fb
fd
strategi
fig
summari
strategi
led
higher
cellspecif
yield
compar
typic
process
ccd
sinc
cell
analyz
strategi
origin
one
singl
hcdcultiv
calcul
volumetr
product
correspond
medium
util
strategi
cell
growth
phase
calcul
base
v
w
toi
way
medium
util
toi
consid
lower
fb
fd
strategi
v
w
ml
compar
dme
v
w
ml
accordingli
fd
strategi
provid
best
volumetr
product
sinc
provid
lowest
medium
consumpt
cell
expans
phase
produc
highest
amount
viru
particl
tabl
overal
fd
strategi
optim
combin
low
medium
consumpt
high
yield
anoth
posit
featur
substrat
feed
fedbatch
mode
viru
lost
earli
stage
infect
help
reach
higher
fraction
infect
cell
high
titer
hpi
fig
without
reach
limit
glucos
concentr
time
point
first
harvest
also
consid
collect
highli
concentr
supernat
avoid
accumul
byproduct
neg
impact
viru
replic
compar
time
cours
viru
titer
fig
furthermor
transfer
cell
suspens
new
vessel
requir
fd
strategi
repres
advantag
fb
report
vefbatch
regard
oper
larg
bioreactor
accord
increas
cell
concentr
strategi
result
product
titer
time
higher
titer
typic
obtain
ccd
also
observ
regard
slight
increas
cellspecif
yield
even
signific
consider
increas
volumetr
product
four
time
case
fd
strategi
tabl
implement
dme
fd
strategi
largescal
vaccin
manufactur
sever
limit
taken
account
exampl
product
scale
medium
exchang
product
harvest
done
fast
scaledown
system
accordingli
use
atf
hollow
fiber
system
adequ
membran
cutoff
consid
base
result
obtain
adapt
optim
cultur
format
focu
adequ
substrat
suppli
cell
immedi
infect
also
optim
dilut
possibl
inhibitor
infect
appropri
viru
harvest
interv
highcelldens
hcd
cultiv
crpix
cell
bioreactor
use
atfbas
perfus
system
result
similar
specif
cell
growth
rate
previous
report
cell
line
conventionalcelldens
ccd
cultur
parent
cell
line
cr
optimum
cell
prolifer
obtain
stoichiometr
determin
perfus
rate
base
specif
cell
growth
rate
optim
suppli
nutrient
exponenti
phase
averag
specif
growth
rate
h
achiev
minimum
medium
consumpt
combin
complet
medium
exchang
prior
infect
cell
concentr
ml
shake
flask
ml
v
w
increas
even
cellsml
viru
infect
cell
popul
exceed
cellsml
seem
feasibl
scaledown
shake
flask
optim
hcd
cultiv
demonstr
capac
crpix
cell
achiev
specif
growth
rate
h
h
futur
scaleup
studi
may
achiev
increas
cell
prolifer
paramet
shake
flask
cultiv
approxim
bioreactor
paramet
may
includ
unregul
ph
profil
batch
cultiv
phase
ph
decreas
lactat
accumul
indirect
ph
regul
exchang
medium
perfus
phase
dissolv
oxygen
andor
stir
speed
may
also
underestim
perhap
adjust
avoid
gradient
analysi
scaledown
model
shake
flask
suggest
maximum
viru
yield
depend
high
viabil
cell
toi
increas
condit
medium
replac
time
point
partial
medium
replac
may
dilut
inhibitori
metabolit
replenish
nutrient
deplet
cell
prolifer
phase
one
process
design
take
observ
account
employ
complet
medium
exchang
follow
fedbatch
interv
strategi
good
option
especi
virus
replic
cycl
longer
time
need
deplet
avail
glucos
given
initi
medium
exchang
first
critic
stage
overcom
semi
continu
medium
exchang
could
appli
collect
infecti
viru
materi
avoid
accumul
toxic
byproduct
combin
option
allow
increas
cellspecif
viru
yield
compar
ccd
cultiv
achiev
high
volumetr
product
hcd
overal
studi
demonstr
replic
mva
inhibit
high
host
cell
densiti
present
gener
method
employ
maxim
yield
cell
culturederiv
vaccin
virus
use
exist
bioreactor
coupl
perfus
system
hcd
cultiv
potenti
outperform
convent
product
strategi
implement
addit
optim
focus
challeng
scaleup
discuss
consequ
studi
cultur
format
may
also
allow
semi
continu
cellfre
viru
harvest
thu
simplifi
subsequ
downstream
process
